|
LEAP-005: A phase II multicohort study of lenvatinib plus pembrolizumab in patients with previously treated selected solid tumors—Results from the gastric cancer cohort. |
|
|
Consulting or Advisory Role - Amgen; Beigene; Bristol-Myers Squibb; Celltrion; Gloria Biosciences; Lilly; Merck Serono; MSD; Quintiles; Taiho Pharmaceutical; Zymeworks |
Speakers' Bureau - Foundation medicine; Lilly; Merck Serono |
Research Funding - Amgen; Beigene; Bristol-Myers Squibb; GlaxoSmithKline; Lilly; Merck Serono; MSD; Taiho Pharmaceutical |
|
|
|
Consulting or Advisory Role - Abbvie; AstraZeneca; Merck; Roche |
Speakers' Bureau - AstraZeneca |
Research Funding - Abbvie; Bristol-Myers Squibb |
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb |
|
|
Honoraria - AstraZeneca; Genentech/Roche; Pierre Fabre |
Consulting or Advisory Role - Bristol-Myers Squibb; Erytech Pharma; Genentech/Roche; Novartis |
Research Funding - Genentech/Roche (Inst) |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Genentech/Roche; Pierre Fabre |
|
|
Honoraria - Amgen; Bayer; Bristol-Myers Squibb; Celgene; Ferrer; Lilly; Merck; MSD; Roche; Sanofi; SERVIER |
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Lilly; MSD; Roche; SERVIER |
Travel, Accommodations, Expenses - Amgen; Bayer; Bristol-Myers Squibb; Celgene; Ferrer; Lilly; Merck; MSD; Roche; Sanofi; SERVIER |
|
|
Consulting or Advisory Role - Bristol-Myers Squibb; Merck Serono |
Research Funding - Abbvie; Amgen; Astellas Pharma; Bristol-Myers Squibb; MSD; Pfizer; Roche |
|
|
Consulting or Advisory Role - Bristol-Myers Squibb; Roche |
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; MSD; Roche |
|
|
Honoraria - Clinigen Group |
Research Funding - Pfizer (Inst) |
|
|
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Eisai; Merck; Roche Canada |
Research Funding - AstraZeneca; Merck |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Eisai; Novartis |
Speakers' Bureau - Basilea; Roche |
|
|
Consulting or Advisory Role - Genmab (Inst); Roche (Inst) |
Speakers' Bureau - Eisai (Inst) |
Research Funding - Celgene (Inst) |
Travel, Accommodations, Expenses - Bayer |
|
|
Consulting or Advisory Role - Abbvie; Celgene; Ipsen; Novartis; Perthera |
|
Travel, Accommodations, Expenses - Halozyme |
|
|
Honoraria - Bristol-Myers Squibb; Medison; Merck Sharp & Dohme; Novartis |
|
|
No Relationships to Disclose |
|
|
|
|
|
|
|
|
|
Stock and Other Ownership Interests - Merck |
Travel, Accommodations, Expenses - Merck; Merck |
|
|
Employment - Merck Sharp & Dohme |
Stock and Other Ownership Interests - Merck |
|
|
Consulting or Advisory Role - Bristol-Myers Squibb; MSD |
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; MSD |